Digital Health Meetings

DTx-Drug combinations can improve the treatment value, thus leading to better patient outcomes. Join HealthXL in this session to discuss this topic with thought leaders in this space.

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. Join this 2 part sprint to establish 5 key challenges and agree on 5 key recommendations to overcome them with your peers working in this space.

Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part meeting to establish 5 key challenges and agree on 5 key recommendation to overcome them.

The reimbursement path for digital health solutions in Europe has always been complex to navigate. Join this Masterclass led by Aymeric Perchant to deep dive into this topic.

Due to the lack of industry-wide evidence frameworks for digital health solutions in oncology, regulators' and payers' requirements are usually the same as drugs. Join HealthXL in this meeting to deep dive into this topic.

While the number of partnerships between DTx and Pharma have grown in the past years, we haven’t seen big successes yet, and part of that could be due to bad roadmap definition and its execution. Join your peers in this meeting to discuss this topic further

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.

In Neurodegenerative Diseases, aging is a risk factor and as the older populations grow, its prevalence increases, leading to an enormous burden on healthcare systems. Join this meeting to deep dive into this topic with other senior leaders in this field.

Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join this meeting to deep dive into this topic with your peers working in this space.

Join us for our next HealthXL Webinar 'Metaverse in Healthcare' where we will take a deeper look at the potential the metaverse has in the healthcare space.

Oncology services have changed in recent years from the way cancer is diagnosed to how treatment is being delivered. Join other senior leaders in this session to deep dive into this topic.

Proving clinical efficacy is one of the biggest challenges for SaMD manufacturers. However, it is key to getting buy-in from stakeholders. Join this Masterclass led by Shaheen Lakhan (Chief Medical Officer, Click Therapeutics) to depp dive into this topic with other senior leaders in this area.

Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part Sprint where we will break this topic down into 5 key challenges and agre on 5 key recommendations to overcome the challenges.

There is no question that Big Tech has the capability to disrupt healthcare, though the complexity of healthcare ecosystems is not making it easy for these companies. Join this meeting to dive deeper into this topic and discuss how Big Tech is getting into digital health.

Many DTx companies target payers to get reimbursed, but very few vendors get what they are looking for. Join this meeting to deep dive into this topic with other senior leaders in this area.

‍

Real-World Data (RWD) can be highly valuable for many stakeholders in healthcare, such as pharma, MedTech, payers, or hospitals. Join this Masterclass, led by Philip Russmeyer (Founder, FITFILE) to discuss this topic further.

Cardiovascular diseases (CVD) have been at the forefront of digital health innovations. Join HealthXL in this meeting where we will focus on the use of digital health tools for the prediction of cardiovascular events.

Physician adoption is one of the keys to unlocking the revenues expected from DTx solutions. Join HealthXL in this meeting to discuss this topic with other senior leaders in this field.

‍

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join us in this interactive masterclass led by Dr. Victor Stephani (responsible for Market Access and Chief of Staff at HelloBetter) to discuss this topic further.

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Biomarkers partners to discuss mutual challenges they face when building successful collaborations. Seats are limited so apply now to join this session.

In a complex disease area like oncology, treatments usually cause adverse effects that compromise patients' quality of life. Join this session to discuss this topic further with your peers working in this field.

While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join Part 2 of this sprint where we will continue this discussion and break this down into 5 key challenges and agree on 5 key recommendations to overcome them.

Over the last few years, partnerships between digital therapeutics (DTx) and Life Sciences companies have grown exponentially. Join HealthXL in this meeting to discuss this topic with thought leaders in this area.

Digital health solutions can track a huge amount of data points, but tracking too many different measures can make you lose focus. Join HealthXL in this meeting to discuss this with other thought leaders working in this area.

‍

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book your place in this bilateral discussion.

When the pandemic was hitting the world, venture capitalists invested more than ever in Digital Therapeutics (DTx) as the world was moving away from the traditional in-person care settings, and patients needed new ways to access care and treatments. Join HealthXL to discuss this topic with your peers working in this area.

In a world where customers are used to excellent user experience (e.g. Google, Amazon, Apple, etc.), DTx companies need to meet customers' expectations. Join other senior leaders in this session to discuss what the success metrics of patient engagement are for DTx solutions.

Are you considering clinical validation for a SaMD or SaMD/PDT+drug combination product? Join this meeting to discuss this topic further with others working in this field

As more DTx-drug combinations emerge, regulation is becoming increasingly important. Join HealthXL in this meeting to dive deeper into this topic.

Clinical trials are thoughtfully designed and implemented to ensure the right patients are involved, quality standards are strictly followed, and the endpoints selected are the right ones to show the drug’s safety and effectiveness. Join HealthXL in this discussion to dive deeper into this topic.

Digital solutions have great potential in mental health, improving care access, symptom tracking, and treatment personalization. Join HealthXL in this meeting to discuss this topic further with your peers working in this area.

‍

While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join this two part session to discuss this topic further.

‍

Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join HealthXL in this meeting to discuss this further.

Join this masterclass led by Tahir Rizvi (Head of Quality Assurance and Regulatory Affairs at Caption Health) and Armen Vidian (Digital Health Venture Capitalist) to learn more about the regulatory considerations for AI-based solutions in the US.

‍

Are you a digital therapeutics (DTx) company seeking reimbursement in the US market? Join this masterclass led by the biopharma and DTx reimbursement expert Mike Pace to dive deeper into this topic.

Are you a digital health company looking to fundraise, acquire new customers or hire key executives? If so, crafting a story that inspires, builds trust, and drives credibility is critical. 

‍

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

In this webinar with Ankita Deshpande (Head of Innovation Accelerator at Alexion Pharmaceuticals), we will deep dive into the unique opportunities and challenges of digital health in rare diseases. Register now to secure your place!

What are the best models for DTx in the US in this new reality? How will the business models change in the future? Join us in a peer-to-peer conversation where we will discuss these questions and more!

Healthcare is one of those areas that one would expect to be more human-centric, at the end of the day, what is more human than getting sick? Join HelathXL in this masterclass led by Kellee M. Franklin, PhD, Founder of Mindful Innovation Labs, and Carole Tremonti, VP Clinical Strategy at Project Cronin, where they will discuss how we can be more human-centric when creating digital health solutions for patients and the care team.

While the digital therapeutics (DTx) market is increasingly growing, it is still small compared to large players in the healthcare industry such as pharma. Join HealthXL in this peer-to-peer discussion to deep dive into this topic.

Join this meeting to take a deep dive into what the best business models will be in the next few years for virtual care companies in the diabetes space.

Are you trying to commercialize a digital therapeutics (DTx) solution in the European Union (EU)? Would you like to learn practical steps on how to navigate the European regulatory landscape? Keep reading, this masterclass is for you!

‍

The right commercialization model for a digital health product is a key component of success in this rapidly growing space. Join this masterclass led by Steven Vandeput, PhD, to discuss this topic further.

Pharma companies are huge corporations with complex operations to ensure the quality of their products and services. Join HealthXL in this meeting to deep dive into this topic with others working in this space.

The accelerated growth of the virtual care industry since the pandemic has opened many opportunities for virtual care companies. Join HealthXL in this meeting to dive deeper into this topic and discuss further with your peers working in this space.

Digital therapeutics (DTx) and drugs are very different care solutions. However, DTx are often compared to traditional pharmaceutical products because the terminology and definitions are unclear. Join this meeting to discuss this topic further with your peers.

Most digital health companies in oncology will struggle to get their products in the market on their own. Join HealthXL in this meeting to discuss the do's and don'ts when seeking partnerships for digital health companies in oncology.

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Are you trying to figure out what is the best distribution channel for your digital therapeutics (DTx) solution? Join this meeting to discuss this topic further with your peers working in this space.

Digital health companies can take different routes to market, however, finding the one that is sustainable and scalable in the long term, is not an easy task. Join this meeting to discuss this topic further with others working in this space.

What makes for a successful business model for digital companies in mental health? Join us in this fireside chat with Russell Glass, CEO at Headspace Health, where we will deep dive into the business models for digital companies in the mental health space. Register now to secure your place.

Are you targeting payers as part of your market access strategy? What do you need to know about their evidence requirements for DTx? Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Are you a digital therapeutics (DTx) start-up seeking capital? How can companies get attention from investors in an increasingly competitive industry? Join HealthXL in this meeting to discuss this topic further with others working in this space.

The definition of Digital Therapeutics (DTx) is broad, including many different solutions, making it hard to agree on the evidence generation standards. Join this meeting to dive deeper into this topic and learn from your peers working in this area.

Are you trying to get your DTx solution regulated in the US? Would you like to learn from the experiences of a real company? Join HealthXL in this masterclass led by Michelle Rubin-Onur from Blue Note Therapeutics to dive deeper into this topic

The investment case for digital health solutions is straightforward in many therapeutic areas, such as diabetes, oncology, mental health, women’s health, among others.

Join HealthXL's next webinar with Julie Murchinson, Partner at Transformation Capital, as we discuss growth and scalability strategies in digital health. Apply now to secure your place.

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book you place in this meeting.

While new legislations and rules (such as DiGA in Germany) have opened new options for reimbursement, adoption of digital therapeutics (DTx) remains insufficient to achieve the revenue expected from these solutions. Join this 2 part sprint to discuss this topic further.

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book your place in this event.

What are the best incentive models to encourage health care professionals (HCPs) and care teams to adopt digital health in oncology? Join this meeting to discuss this topic further with others working in this space.

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. Join this Masterclass led by BrightInsight to dive deeper into this topic and discuss this further with your peers working in this space.

Are you a DTx or Pharma company seeking wide-spread reimbursement of a DTx product in the US? Join this Masterclass led by Mike Pace to learn more about this topic and share your experiences with others working in this space.

With the pandemic, we saw a rapid expansion of telemedicine and remote patient monitoring (RPM) solutions as a new way of delivering healthcare. Join HealthXL in this meeting to discuss this topic further with others working in this space.

The investment case for digital health and oncology is straightforward - apply digital innovation to one of the most prevalent diseases worldwide, improve millions of patients' lives, and reap the rewards. Join your peers in this meeting to dive deeper into this topic.

Standalone digital therapeutics (DTx) solutions are not comparable to drugs or standard treatment protocols. Join this meeting to dive deeper into this topic with others working in this space.

How to successfully take a DTx product through the regulatory pathways in the US? Join this Masterclass led by Jason Brooke, medical device attorney and regulatory/quality advisor, as we dive deeper into this topic.

Join our next HealthXL Webinar with Cristina Duran, Chief Digital Health Officer R&D at AstraZeneca, as we discuss Digital Health in Oncology. Register now to secure your place!

Spotify, Disney, Amazon, what do all of these organizations have in common? Top class customer experience. Join this Masterclass led by Sutherland to learn more about successful customer experience strategies and how pharma and medtech companies can improve their customers' experience.

What is the partnership roadmap for pharma and digital therapeutics (DTx) companies collaborations? Join your peers working in this space to learn more about this topic and share your experiences.

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

‍

‍

How can we leverage technological advancements to drive an explosive evolution in pathology? Join this Masterclass led by Bill Taranto to dive deeper into this topic.

As the Digital Therapeutics (DTx) industry matures, regulation is becoming increasingly important. Join this meeting to share your experiences with others working in this space.

How can we design trials for our digital health tools so they are rigorously validated and regulated? Join this Masterclass led my Akili Interactive to learn more about this topic.

Within digital therapeutics (DTx), mental health is an area showing major potential, particularly given that drug compliance tends to be a considerable problem and pharmacological treatments are usually not enough to get the desired outcomes. Join this meeting to dive deeper into this topic and share your experiences with others in the field.

A company might be able to create excellent virtual care solutions, but it won't have much of an impact if no one uses them. Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

The marriage of digital health and oncology is very new, with companies still figuring out the best approach to establish in the market. Join this meeting to discuss this topic further with others working in this field.

Regulatory clearance and the best commercialization model for a digital health product are among the key components for success in a rapidly growing sector. Join this Masterclass led by Flying Health to dive deeper into this topic.

Millions of people worldwide suffer from immune-mediated, inflammatory conditions (IMIDs) such as rheumatoid arthritis, atopic dermatitis, psoriasis, ulcerative Colitis, and multiple sclerosis, to name a few. Join this meeting to discuss this and share your experiences with others working in this space.

As the Covid-19 pandemic shifted how people interact with healthcare, the relationship between pharma and patients changed as many moved away from conventional clinical settings. Join this meeting to discuss this topic further and share your thoughts and experiences with your peers.

Are you a Digital Health company, Pharma executive, Medtech executive, or Venture Capitalist (VC), working in Patient Support Programs (PSPs) in oncology and seeking guidance to build successful partnerships? Then keep reading, this meeting is for you

Real-world data (RWD) can be highly valuable to pharma companies; with several use cases from drug discovery and development to drug market access, label extensions, and understanding how their drugs and competitors are used in real life. Join this meeting to discuss this topic further with others working in this space.

While the relationship between digital therapeutics (DTx) and pharma is still in its infancy, we are seeing the emergence of some compelling models and partnerships that illustrate the opportunities in the market. Join HealthXL in this meeting to dive deeper into this topic.

As the digital health industry grows exponentially, patients and providers are being flooded by hundreds of digital health products. Join this meeting to share your experiences and learn from others working in this space.

Are you struggling with trial design for your digital health products? Join this meeting to discuss this further with others working in this space.

Are you trying to get your SaMD product regulated in the European Union (EU)? Join HelathXL in this meeting to discuss this topic further with others working in this space.

Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Novel digital biomarkers have the potential to be part of clinical trials, but there are still a lot of questions regarding their reliability and validation process. Join this meeting to discuss this topic further with your peers in the field.

Are you struggling with getting HCPs and patients to adopt your digital health solution in oncology? Apply now to join this series of two meetings to discuss this topic further and learn from your peers.

Join our upcoming webinar with Robert Garber from 7wireVentures as we discuss how to get funding for a digital health solution.

Are you a DTx or Pharma company seeking coverage of your DTx in the US market? How should we be thinking about value-based agreements (VBA) in the context of DTx reimbursement in the US? Join this masterclass led by biopharma and PDT outcomes-based contracting pioneer, Mike Pace, to dive deeper into this topic.

DTx-drug combinations (‘combo’) are becoming one of the easiest ways for digital therapeutics (DTx) companies to commercialize their products through pharma. Join this meeting to discuss this topic with others working in the Digital Therapeutics space.

Most digital therapeutics (DTx) companies opt to pursue B2B business models, such as partnerships with pharma, employers or payers. Join this meeting to discuss this further with other members working in this space.

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join this interactive masterclass led by Dr Victor Stephani to dive deeper into this topic and discuss the matter further with your peers in this field.